From a pharmacy newsletter:
Israel’s Teva Pharmaceutical Industries has launched a generic version of Axiron (testosterone) topical solution in the USA. Teva’s generic launch of this treatment, which follows that of Ireland-incorporated Perrigo in July, comes on the back of the US District Court for the Southern District of Indiana. That decision, appealed by Lilly and its Acrux, has paved the way for generics to enter the market.
Israel’s Teva Pharmaceutical Industries has launched a generic version of Axiron (testosterone) topical solution in the USA. Teva’s generic launch of this treatment, which follows that of Ireland-incorporated Perrigo in July, comes on the back of the US District Court for the Southern District of Indiana. That decision, appealed by Lilly and its Acrux, has paved the way for generics to enter the market.